Thursday, February 21, 2019 3:13:04 PM
Alan,
Thanks for your inquiry. At this time, we are struggling with keeping the current business plan funded. We have not been able to attract sufficient venture capital to cover current G&A expenses let alone furthering clinical trials and product development. We have done extensive broker roadshows via Renmark for two years and have used other methods to identify sources of capital and to find investors willing to back the company. In our last fiscal year this amounted to dozens of presentations in cities all over Canada and the US that were attended by over 300 brokers. Over the last six months, insiders have loaned the company over $300,000 until proper financing could be put into place. The lack of outside investor interest is forcing us to look at any all options from selling the technology to joint ventures. If you have any ideas for us to consider please do send them along.
Eric
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM